Reilley, M. J., Morrow, B., Ager, C. R., Liu, A., Hong, D. S., & Curran, M. A. (2019). TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma. J Immunother Cancer.
Citación estilo ChicagoReilley, Matthew J., Brittany Morrow, Casey R. Ager, Arthur Liu, David S. Hong, and Michael A. Curran. "TLR9 Activation Cooperates With T Cell Checkpoint Blockade to Regress Poorly Immunogenic Melanoma." J Immunother Cancer 2019.
Cita MLAReilley, Matthew J., et al. "TLR9 Activation Cooperates With T Cell Checkpoint Blockade to Regress Poorly Immunogenic Melanoma." J Immunother Cancer 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.